DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,509,516 | +2.8% | 42,360 | -0.6% | 2.38% | +7.5% |
| Q2 2023 | $10,224,480 | -1.6% | 42,602 | +3.3% | 2.22% | -6.5% |
| Q1 2023 | $10,393,373 | +94929.5% | 41,237 | +0.1% | 2.37% | -8.1% |
| Q4 2022 | $10,937 | -99.9% | 41,205 | +0.6% | 2.58% | -6.1% |
| Q3 2022 | $10,576,000 | +1.9% | 40,947 | +0.0% | 2.75% | +10.8% |
| Q2 2022 | $10,376,000 | -16.3% | 40,927 | -3.1% | 2.48% | -5.1% |
| Q1 2022 | $12,393,000 | -11.9% | 42,250 | -1.2% | 2.62% | -7.8% |
| Q4 2021 | $14,063,000 | +7.3% | 42,744 | -0.7% | 2.84% | -2.7% |
| Q3 2021 | $13,108,000 | +10.8% | 43,057 | -2.3% | 2.92% | +9.4% |
| Q2 2021 | $11,827,000 | +13.5% | 44,072 | -4.8% | 2.67% | +6.9% |
| Q1 2021 | $10,422,000 | -0.3% | 46,305 | -1.6% | 2.49% | -6.1% |
| Q4 2020 | $10,454,000 | +1.7% | 47,060 | -1.4% | 2.66% | -6.1% |
| Q3 2020 | $10,280,000 | +25.2% | 47,740 | +2.8% | 2.83% | +0.2% |
| Q2 2020 | $8,209,000 | +27.5% | 46,422 | -0.2% | 2.82% | +9.0% |
| Q1 2020 | $6,438,000 | -10.6% | 46,512 | -0.8% | 2.59% | +9.9% |
| Q4 2019 | $7,200,000 | +4.7% | 46,909 | -1.5% | 2.36% | -0.5% |
| Q3 2019 | $6,876,000 | -1.2% | 47,610 | -2.2% | 2.37% | -2.8% |
| Q2 2019 | $6,960,000 | +7.8% | 48,700 | -0.4% | 2.44% | +2.9% |
| Q1 2019 | $6,455,000 | +27.1% | 48,895 | -0.8% | 2.37% | +10.9% |
| Q4 2018 | $5,080,000 | -3.9% | 49,265 | +1.3% | 2.14% | +6.1% |
| Q3 2018 | $5,284,000 | +9.6% | 48,633 | -0.4% | 2.02% | +3.5% |
| Q2 2018 | $4,821,000 | +0.3% | 48,851 | -0.5% | 1.95% | -0.1% |
| Q1 2018 | $4,806,000 | +5.7% | 49,081 | +0.2% | 1.95% | +9.6% |
| Q4 2017 | $4,546,000 | +8.1% | 48,973 | -0.1% | 1.78% | +3.1% |
| Q3 2017 | $4,207,000 | +1.9% | 49,043 | +0.2% | 1.72% | -1.4% |
| Q2 2017 | $4,130,000 | -1.3% | 48,943 | +0.1% | 1.75% | -5.3% |
| Q1 2017 | $4,183,000 | +8.9% | 48,906 | -0.9% | 1.85% | +3.6% |
| Q4 2016 | $3,841,000 | -0.9% | 49,346 | -0.2% | 1.78% | -1.2% |
| Q3 2016 | $3,876,000 | -21.5% | 49,439 | +1.2% | 1.80% | -22.8% |
| Q2 2016 | $4,935,000 | +4.2% | 48,857 | -2.1% | 2.34% | -0.3% |
| Q1 2016 | $4,735,000 | +1.9% | 49,914 | -0.2% | 2.34% | -1.8% |
| Q4 2015 | $4,647,000 | +8.1% | 50,027 | -0.8% | 2.39% | -0.2% |
| Q3 2015 | $4,297,000 | -1.0% | 50,430 | -0.6% | 2.39% | +4.1% |
| Q2 2015 | $4,340,000 | +1.9% | 50,710 | +1.1% | 2.30% | +0.9% |
| Q1 2015 | $4,260,000 | -3.1% | 50,180 | -2.2% | 2.28% | -0.8% |
| Q4 2014 | $4,396,000 | +12.8% | 51,294 | +0.0% | 2.29% | +9.1% |
| Q3 2014 | $3,896,000 | +4.3% | 51,277 | +8.1% | 2.10% | -5.3% |
| Q2 2014 | $3,736,000 | -1.2% | 47,454 | -5.9% | 2.22% | +6.2% |
| Q1 2014 | $3,782,000 | -3.1% | 50,427 | -0.2% | 2.09% | -5.4% |
| Q4 2013 | $3,902,000 | +320.5% | 50,542 | +277.5% | 2.21% | -7.6% |
| Q3 2013 | $928,000 | – | 13,390 | – | 2.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |